US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

MAIA Biotechnology Inc.

1.40

+0.06004.48%

Post-market: 1.400.00000.00%18:49 EDT

Volume:906.42K

Turnover:1.26M

Market Cap:84.94M

PE:-2.30

High:1.42

Open:1.35

Low:1.34

Close:1.34

52wk High:3.19

52wk Low:0.8700

Shares:60.67M

Float Shares:55.61M

Volume Ratio:1.27

T/O Rate:1.63%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.6085

EPS(LYR):-0.7000

ROE:-218.68%

ROA:-92.10%

PB:4.11

PE(LYR):-2.00

Loading ...

Overview Company News Filings

Maia Biotechnology - Ateganosine Plus Cemiplimab Shows Acceptable Safety Profile in Heavily Pre-treated Patients

THOMSON REUTERS

Maia Biotechnology Reports Strong Initial Efficacy Data in Third-line Non-small Cell Lung Cancer from Phase 2 Thio-101 Part C Expansion Trial

THOMSON REUTERS

Maia Biotechnology - Thio-101 Part C Shows 90.5% Disease Control Rate in 3L Nsclc

THOMSON REUTERS

Maia Biotechnology - Ateganosine Plus Cemiplimab Outperforms Standard Chemotherapy Dcr in 3L Nsclc

THOMSON REUTERS

Maia Biotechnology Completes International Enrollment in Part C of Phase 2 Thio-101 Expansion Trial in Third-line Non-small Cell Lung Cancer

THOMSON REUTERS

MAIA Biotechnology Completes International Enrollment in Part C of Phase 2 THIO-101 Expansion Trial in Third-Line Non-Small Cell Lung Cancer

Maia Biotech opens enrollment at Emory Winship for Phase 2 ateganosine NSCLC trial

Maia Biotechnology Opens Enrollment for Phase 2 Expansion Trial of Novel Telomere-Targeting Agent at Winship Cancer Institute of Emory University

THOMSON REUTERS

Compugen to Unveil Latest Data from MAIA Ovarian Cancer Drug Trial at European Conference

Maia Biotech opens enrollment at second US site for Phase 2 THIO-101 lung cancer trial expansion

Maia Biotechnology Activates and Opens Enrollment at Second U.S. Clinical Site for International Phase 2 Thio-101 Expansion Trial

THOMSON REUTERS

MAIA Biotechnology Activates and Opens Enrollment at Second U.S. Clinical Site for International Phase 2 THIO-101 Expansion Trial

MAIA Biotechnology reports 29 patients dosed in Phase 3 THIO-104 trial

MAIA Biotech doses 29 patients in Phase 3 THIO-104 lung cancer trial

Maia Biotechnology Reports Strong Enrollment and Dosing Momentum in Pivotal Phase 3 Non-Small Cell Lung Cancer Trial

THOMSON REUTERS

MAIA Gets FDA Clearance for Enrollment in Expanded Phase 2 Cancer Study

MT Newswires Live

MAIA Biotechnology receives FDA clearance for amendment to IND application

Maia Biotechnology Receives FDA Clearance to Open U.S. Enrollment in Ongoing Phase 2 Thio-101 Trial Expansion

THOMSON REUTERS

MAIA Biotechnology announces open market purchases by CEO, director

Analysts Offer Insights on Healthcare Companies: West Pharmaceutical Services (WST) and MAIA Biotechnology, Inc. (MAIA)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigerfiesta.com/stock/MAIA/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MAIA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MAIA\",,,,,undefined,":{"symbol":"MAIA","market":"US","secType":"STK","nameCN":"MAIA Biotechnology Inc.","latestPrice":1.4,"timestamp":1789588800000,"preClose":1.34,"halted":0,"volume":906418,"hourTrading":{"tag":"盘后","latestPrice":1.4,"preClose":1.4,"latestTime":"18:49 EDT","volume":3209,"amount":4572.3317767,"timestamp":1789598990401,"change":0,"changeRate":0,"amplitude":0.035714},"delay":0,"changeRate":0.04477611940298495,"floatShares":55605100,"shares":60671491,"eps":-0.608478,"marketStatus":"Post-Mkt","change":0.06,"latestTime":"09-16 18:51:17 EDT","open":1.35,"high":1.42,"low":1.34,"amount":1260266.2746162,"amplitude":0.059701,"askPrice":1.48,"askSize":5,"bidPrice":1.38,"bidSize":6,"shortable":3,"etf":0,"ttmEps":-0.608478,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789603200000},"marketStatusCode":4,"adr":0,"listingDate":1659067200000,"exchange":"AMEX","adjPreClose":1.34,"preHourTrading":{"tag":"盘前","latestPrice":1.38,"preClose":1.34,"latestTime":"09:29 EDT","volume":18101,"amount":24864.192476400003,"timestamp":1789565398538,"change":0.04,"changeRate":0.029851,"amplitude":0.029403},"postHourTrading":{"tag":"盘后","latestPrice":1.4,"preClose":1.4,"latestTime":"18:49 EDT","volume":3209,"amount":4572.3317767,"timestamp":1789598990401,"change":0,"changeRate":0,"amplitude":0.035714},"volumeRatio":1.274554},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MAIA\",,,,,undefined,":{"symbol":"MAIA","floatShares":55605100,"roa":"-92.10%","roe":"-218.68%","lyrEps":-0.7,"volumeRatio":1.274554,"shares":60671491,"dividePrice":0,"high":1.42,"amplitude":0.059701,"preClose":1.34,"low":1.34,"week52Low":0.87,"pbRate":"4.11","week52High":3.19,"institutionHeld":0,"latestPrice":1.4,"committee":0.090909,"eps":-0.608478,"divideRate":0,"volume":906418,"delay":0,"ttmEps":-0.608478,"open":1.35,"prevYearClose":1.53,"prevWeekClose":1.3,"prevMonthClose":1.31,"prevQuarterClose":1.44,"fiveDayClose":1.33,"twentyDayClose":1.37,"sixtyDayClose":1.38},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MAIA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-10","symbol":"MAIA","fiscalQuarterEnding":"2026/06","expectedEps":-0.11,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786334400000,"reportTimeType":"pre","actualEps":-0.13},{"market":"US","date":"2026-05-11","symbol":"MAIA","fiscalQuarterEnding":"2026/03","expectedEps":-0.18,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778472000000,"reportTimeType":"pre","actualEps":-0.14},{"market":"US","date":"2026-03-23","symbol":"MAIA","fiscalQuarterEnding":"2025/12","expectedEps":-0.13,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1774238400000,"reportTimeType":"pre","actualEps":-0.08},{"market":"US","date":"2025-11-07","symbol":"MAIA","fiscalQuarterEnding":"2025/09","expectedEps":-0.19,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1762491600000,"reportTimeType":"post","actualEps":-0.27},{"market":"US","date":"2025-08-11","symbol":"MAIA","fiscalQuarterEnding":"2025/06","expectedEps":-0.24,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1754884800000,"reportTimeType":"pre","actualEps":-0.18}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MAIA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MAIA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1677038400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MAIA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MAIA","date":"2026-09-15","current":-2.202216,"percent":0.243083,"low":-5.555213,"twenty":-3.243235,"median":-2.525562,"eighty":-1.836858,"high":-0.77644,"avg":-2.520786,"sd":0.784151,"marketCap":84547923},"quantilePoints":[{"date":"2022-07-29","current":-4.130799,"twenty":-3.74477,"median":-3.33193,"eighty":-3.032982,"marketCap":61688243},{"date":"2022-08-05","current":-3.418592,"twenty":-4.327368,"median":-3.717719,"eighty":-3.321732,"marketCap":51052339},{"date":"2022-08-12","current":-3.539667,"twenty":-3.942776,"median":-3.513542,"eighty":-3.113768,"marketCap":52860442},{"date":"2022-08-19","current":-2.813217,"twenty":-3.757603,"median":-3.418592,"eighty":-3.057447,"marketCap":42011820},{"date":"2022-08-26","current":-2.813564,"twenty":-3.645074,"median":-3.16932,"eighty":-3.031815,"marketCap":41665794},{"date":"2022-09-02","current":-3.160645,"twenty":-3.562458,"median":-3.149236,"eighty":-2.973073,"marketCap":46805669},{"date":"2022-09-09","current":-3.035105,"twenty":-3.531121,"median":-3.079413,"eighty":-2.987843,"marketCap":44946565},{"date":"2022-09-16","current":-2.628947,"twenty":-3.505948,"median":-3.054305,"eighty":-2.874118,"marketCap":38931818},{"date":"2022-09-23","current":-2.400022,"twenty":-3.459888,"median":-3.035105,"eighty":-2.808995,"marketCap":35541688},{"date":"2022-09-30","current":-2.436946,"twenty":-3.337714,"median":-3.018069,"eighty":-2.628947,"marketCap":36088483},{"date":"2022-10-07","current":-2.481254,"twenty":-3.200415,"median":-2.976027,"eighty":-2.544762,"marketCap":36744637},{"date":"2022-10-14","current":-2.429561,"twenty":-3.170744,"median":-2.946489,"eighty":-2.506362,"marketCap":35979124},{"date":"2022-10-21","current":-2.326175,"twenty":-3.161577,"median":-2.817793,"eighty":-2.443001,"marketCap":34448097},{"date":"2022-10-28","current":-2.392637,"twenty":-3.156081,"median":-2.809698,"eighty":-2.436946,"marketCap":35432328},{"date":"2022-11-04","current":-2.673255,"twenty":-3.130168,"median":-2.80618,"eighty":-2.436946,"marketCap":39587972},{"date":"2022-11-11","current":-2.861595,"twenty":-3.092705,"median":-2.80618,"eighty":-2.443001,"marketCap":41539705},{"date":"2022-11-18","current":-2.59391,"twenty":-3.074979,"median":-2.80618,"eighty":-2.45489,"marketCap":37653909},{"date":"2022-11-25","current":-2.639153,"twenty":-3.06641,"median":-2.741401,"eighty":-2.463531,"marketCap":38310664},{"date":"2022-12-02","current":-2.782421,"twenty":-3.056964,"median":-2.74683,"eighty":-2.481254,"marketCap":40390385},{"date":"2022-12-09","current":-2.639153,"twenty":-3.048124,"median":-2.714557,"eighty":-2.485685,"marketCap":38310664},{"date":"2022-12-16","current":-2.571289,"twenty":-3.039919,"median":-2.704828,"eighty":-2.491357,"marketCap":37325532},{"date":"2022-12-23","current":-2.526046,"twenty":-3.035105,"median":-2.684395,"eighty":-2.489852,"marketCap":36668778},{"date":"2022-12-30","current":-2.646693,"twenty":-3.035105,"median":-2.669314,"eighty":-2.488344,"marketCap":38420123},{"date":"2023-01-06","current":-2.646693,"twenty":-3.028524,"median":-2.669314,"eighty":-2.494376,"marketCap":38420123},{"date":"2023-01-13","current":-3.008634,"twenty":-3.036309,"median":-2.678825,"eighty":-2.495884,"marketCap":43674156},{"date":"2023-01-20","current":-3.649345,"twenty":-3.053419,"median":-2.693672,"eighty":-2.500398,"marketCap":52974891},{"date":"2023-01-27","current":-3.381885,"twenty":-3.088275,"median":-2.710179,"eighty":-2.507838,"marketCap":49092379},{"date":"2023-02-03","current":-3.566626,"twenty":-3.137263,"median":-2.727137,"eighty":-2.510896,"marketCap":51774125},{"date":"2023-02-10","current":-3.332873,"twenty":-3.167896,"median":-2.752259,"eighty":-2.519723,"marketCap":48380895},{"date":"2023-02-17","current":-3.415817,"twenty":-3.245403,"median":-2.79807,"eighty":-2.525852,"marketCap":49584945},{"date":"2023-02-24","current":-3.566626,"twenty":-3.3193,"median":-2.80618,"eighty":-2.527554,"marketCap":51774125},{"date":"2023-03-03","current":-3.4686,"twenty":-3.350216,"median":-2.813564,"eighty":-2.531068,"marketCap":50351158},{"date":"2023-03-10","current":-3.016174,"twenty":-3.350216,"median":-2.827663,"eighty":-2.542251,"marketCap":43783616},{"date":"2023-03-17","current":-2.473263,"twenty":-3.346445,"median":-2.827663,"eighty":-2.542251,"marketCap":35902565},{"date":"2023-03-24","current":-2.399976,"twenty":-3.342675,"median":-2.81339,"eighty":-2.516804,"marketCap":38927270},{"date":"2023-03-31","current":-2.345739,"twenty":-3.337397,"median":-2.80618,"eighty":-2.495884,"marketCap":38047557},{"date":"2023-04-06","current":-2.284723,"twenty":-3.326087,"median":-2.805042,"eighty":-2.481254,"marketCap":37057881},{"date":"2023-04-14","current":-2.447433,"twenty":-3.292155,"median":-2.76734,"eighty":-2.461933,"marketCap":39697018},{"date":"2023-04-21","current":-2.393197,"twenty":-3.261993,"median":-2.739718,"eighty":-2.455007,"marketCap":38817306},{"date":"2023-04-28","current":-1.958672,"twenty":-3.24842,"median":-2.712368,"eighty":-2.44201,"marketCap":31769373},{"date":"2023-05-05","current":-2.318612,"twenty":-3.242387,"median":-2.695409,"eighty":-2.436946,"marketCap":37607553},{"date":"2023-05-12","current":-2.109365,"twenty":-3.242387,"median":-2.678825,"eighty":-2.414792,"marketCap":34746108},{"date":"2023-05-19","current":-1.988788,"twenty":-3.237189,"median":-2.669314,"eighty":-2.399985,"marketCap":33656034},{"date":"2023-05-26","current":-1.827752,"twenty":-3.208406,"median":-2.654233,"eighty":-2.392749,"marketCap":30930849},{"date":"2023-06-02","current":-2.069306,"twenty":-3.176442,"median":-2.646693,"eighty":-2.379637,"marketCap":35018627},{"date":"2023-06-09","current":-1.988788,"twenty":-3.162198,"median":-2.639153,"eighty":-2.33896,"marketCap":33656034},{"date":"2023-06-16","current":-1.851908,"twenty":-3.160645,"median":-2.635382,"eighty":-2.318791,"marketCap":31339627},{"date":"2023-06-23","current":-1.763338,"twenty":-3.153651,"median":-2.628947,"eighty":-2.307373,"marketCap":29840775},{"date":"2023-06-30","current":-1.731131,"twenty":-3.150302,"median":-2.609948,"eighty":-2.28744,"marketCap":29295738},{"date":"2023-07-07","current":-1.779442,"twenty":-3.141254,"median":-2.59768,"eighty":-2.242232,"marketCap":30113294},{"date":"2023-07-14","current":-1.755286,"twenty":-3.123249,"median":-2.586369,"eighty":-2.20532,"marketCap":29704516},{"date":"2023-07-21","current":-1.851908,"twenty":-3.111184,"median":-2.578041,"eighty":-2.067676,"marketCap":31339627},{"date":"2023-07-28","current":-1.859959,"twenty":-3.104623,"median":-2.56987,"eighty":-2.008112,"marketCap":31475886},{"date":"2023-08-04","current":-1.715028,"twenty":-3.097572,"median":-2.563748,"eighty":-1.974295,"marketCap":29023220},{"date":"2023-08-11","current":-1.557401,"twenty":-3.086713,"median":-2.556208,"eighty":-1.943698,"marketCap":28252239},{"date":"2023-08-18","current":-1.369309,"twenty":-3.075231,"median":-2.531381,"eighty":-1.90827,"marketCap":24840133},{"date":"2023-08-25","current":-1.437022,"twenty":-3.068706,"median":-2.525562,"eighty":-1.887815,"marketCap":26068491},{"date":"2023-09-01","current":-1.316644,"twenty":-3.064492,"median":-2.5071,"eighty":-1.866401,"marketCap":23884743},{"date":"2023-09-08","current":-1.32732,"twenty":-3.056964,"median":-2.495884,"eighty":-1.852819,"marketCap":24078428},{"date":"2023-09-15","current":-1.319779,"twenty":-3.048124,"median":-2.488344,"eighty":-1.851908,"marketCap":23941618},{"date":"2023-09-22","current":-1.161405,"twenty":-3.039919,"median":-2.477259,"eighty":-1.830989,"marketCap":21068624},{"date":"2023-09-29","current":-1.357487,"twenty":-3.035105,"median":-2.458182,"eighty":-1.797155,"marketCap":24625665},{"date":"2023-10-06","current":-1.89294,"twenty":-3.03346,"median":-2.451363,"eighty":-1.795545,"marketCap":34339121},{"date":"2023-10-13","current":-1.696859,"twenty":-3.026246,"median":-2.440654,"eighty":-1.781052,"marketCap":30782081},{"date":"2023-10-20","current":-1.772274,"twenty":-3.023715,"median":-2.436946,"eighty":-1.772274,"marketCap":32150173},{"date":"2023-10-27","current":-1.402736,"twenty":-3.020699,"median":-2.436946,"eighty":-1.772274,"marketCap":25446520},{"date":"2023-11-03","current":-1.538485,"twenty":-3.016174,"median":-2.424938,"eighty":-1.763338,"marketCap":27909087},{"date":"2023-11-10","current":-1.563529,"twenty":-3.013408,"median":-2.414792,"eighty":-1.758507,"marketCap":28319514},{"date":"2023-11-17","current":-1.098625,"twenty":-3.009008,"median":-2.400022,"eighty":-1.737573,"marketCap":19898915},{"date":"2023-11-24","current":-1.0945,"twenty":-3.00802,"median":-2.398918,"eighty":-1.715028,"marketCap":19824192},{"date":"2023-12-01","current":-0.93547,"twenty":-3.003917,"median":-2.393197,"eighty":-1.697272,"marketCap":16943754},{"date":"2023-12-08","current":-0.853009,"twenty":-2.993064,"median":-2.385536,"eighty":-1.662077,"marketCap":15450179},{"date":"2023-12-15","current":-0.830323,"twenty":-2.97455,"median":-2.366078,"eighty":-1.603306,"marketCap":15039276},{"date":"2023-12-22","current":-0.963534,"twenty":-2.967166,"median":-2.34235,"eighty":-1.566156,"marketCap":17452066},{"date":"2023-12-29","current":-1.159983,"twenty":-2.962735,"median":-2.332248,"eighty":-1.560368,"marketCap":21010254},{"date":"2024-01-05","current":-1.113209,"twenty":-2.959095,"median":-2.329178,"eighty":-1.540033,"marketCap":20163067},{"date":"2024-01-12","current":-1.319013,"twenty":-2.946198,"median":-2.318612,"eighty":-1.505189,"marketCap":23890693},{"date":"2024-01-19","current":-1.178692,"twenty":-2.917694,"median":-2.307373,"eighty":-1.461419,"marketCap":21349130},{"date":"2024-01-26","current":-1.262884,"twenty":-2.860841,"median":-2.292944,"eighty":-1.43018,"marketCap":22874067},{"date":"2024-02-02","current":-1.449978,"twenty":-2.853404,"median":-2.250825,"eighty":-1.422652,"marketCap":26262818},{"date":"2024-02-09","current":-1.337722,"twenty":-2.835718,"median":-2.238161,"eighty":-1.406928,"marketCap":24229568},{"date":"2024-02-16","current":-1.472372,"twenty":-2.835615,"median":-2.225173,"eighty":-1.406928,"marketCap":26668418},{"date":"2024-02-23","current":-1.37859,"twenty":-2.835204,"median":-2.173979,"eighty":-1.403205,"marketCap":24969793},{"date":"2024-03-01","current":-1.228539,"twenty":-2.828334,"median":-2.067947,"eighty":-1.384495,"marketCap":22251992},{"date":"2024-03-08","current":-1.312943,"twenty":-2.827663,"median":-2.013443,"eighty":-1.37859,"marketCap":23780755},{"date":"2024-03-15","current":-1.228539,"twenty":-2.827663,"median":-1.99684,"eighty":-1.369309,"marketCap":22251992},{"date":"2024-03-22","current":-1.819364,"twenty":-2.817793,"median":-1.988788,"eighty":-1.369309,"marketCap":32953332},{"date":"2024-03-28","current":-2.508838,"twenty":-2.81441,"median":-1.988788,"eighty":-1.373975,"marketCap":49607008},{"date":"2024-04-05","current":-2.225582,"twenty":-2.813286,"median":-2.013193,"eighty":-1.375141,"marketCap":44006217},{"date":"2024-04-12","current":-2.458256,"twenty":-2.807587,"median":-2.066589,"eighty":-1.376495,"marketCap":48606867},{"date":"2024-04-19","current":-2.040149,"twenty":-2.80618,"median":-2.065155,"eighty":-1.378239,"marketCap":40339679},{"date":"2024-04-26","current":-2.789592,"twenty":-2.80618,"median":-2.083954,"eighty":-1.37859,"marketCap":55158336},{"date":"2024-05-03","current":-3.278811,"twenty":-2.81441,"median":-2.154257,"eighty":-1.383204,"marketCap":64831627},{"date":"2024-05-10","current":-3.008179,"twenty":-2.829708,"median":-2.225173,"eighty":-1.384467,"marketCap":59480445},{"date":"2024-05-17","current":-2.706777,"twenty":-2.835307,"median":-2.225893,"eighty":-1.384495,"marketCap":64214183},{"date":"2024-05-24","current":-3.507054,"twenty":-2.863599,"median":-2.234604,"eighty":-1.387273,"marketCap":83199537},{"date":"2024-05-31","current":-4.040936,"twenty":-2.958014,"median":-2.241717,"eighty":-1.392304,"marketCap":95865084},{"date":"2024-06-07","current":-3.056015,"twenty":-2.984545,"median":-2.267774,"eighty":-1.39972,"marketCap":72499334},{"date":"2024-06-14","current":-3.488644,"twenty":-3.008452,"median":-2.292944,"eighty":-1.402924,"marketCap":82762794},{"date":"2024-06-21","current":-3.157269,"twenty":-3.016174,"median":-2.307373,"eighty":-1.403205,"marketCap":74901421},{"date":"2024-06-28","current":-3.06522,"twenty":-3.024981,"median":-2.311144,"eighty":-1.403205,"marketCap":72717706},{"date":"2024-07-05","current":-3.12045,"twenty":-3.037686,"median":-2.318701,"eighty":-1.404613,"marketCap":74027935},{"date":"2024-07-12","current":-3.516259,"twenty":-3.053559,"median":-2.33218,"eighty":-1.406806,"marketCap":83417909},{"date":"2024-07-15","current":-3.359776,"twenty":-3.057103,"median":-2.332214,"eighty":-1.406847,"marketCap":79705593},{"date":"2024-08-02","current":-2.853508,"twenty":-3.056559,"median":-2.332248,"eighty":-1.406887,"marketCap":67695161},{"date":"2024-08-09","current":-2.448494,"twenty":-3.051102,"median":-2.34235,"eighty":-1.406928,"marketCap":58086816},{"date":"2024-08-16","current":-2.426555,"twenty":-3.049827,"median":-2.33896,"eighty":-1.409608,"marketCap":68135554},{"date":"2024-08-23","current":-2.554268,"twenty":-3.042861,"median":-2.346358,"eighty":-1.412104,"marketCap":71721636},{"date":"2024-08-30","current":-2.383983,"twenty":-3.039749,"median":-2.352417,"eighty":-1.420092,"marketCap":66940193},{"date":"2024-09-06","current":-2.681981,"twenty":-3.036825,"median":-2.358441,"eighty":-1.424007,"marketCap":75307717},{"date":"2024-09-13","current":-2.767124,"twenty":-3.035105,"median":-2.377326,"eighty":-1.427844,"marketCap":77698439},{"date":"2024-09-20","current":-2.426555,"twenty":-3.030169,"median":-2.383983,"eighty":-1.429499,"marketCap":68135554},{"date":"2024-09-27","current":-2.222213,"twenty":-3.024981,"median":-2.383983,"eighty":-1.430561,"marketCap":62397823},{"date":"2024-10-04","current":-2.213699,"twenty":-3.01919,"median":-2.379637,"eighty":-1.432249,"marketCap":62158751},{"date":"2024-10-11","current":-2.247756,"twenty":-3.016174,"median":-2.371702,"eighty":-1.435374,"marketCap":63115039},{"date":"2024-10-18","current":-2.141328,"twenty":-3.012024,"median":-2.358441,"eighty":-1.437022,"marketCap":60126638},{"date":"2024-10-25","current":-2.188156,"twenty":-3.008884,"median":-2.346358,"eighty":-1.441989,"marketCap":61441534},{"date":"2024-10-31","current":-2.389927,"twenty":-3.008452,"median":-2.345739,"eighty":-1.447172,"marketCap":67107079},{"date":"2024-11-08","current":-2.83377,"twenty":-3.007134,"median":-2.34725,"eighty":-1.453828,"marketCap":79569822},{"date":"2024-11-15","current":-1.968024,"twenty":-3.002269,"median":-2.346358,"eighty":-1.460958,"marketCap":51049313},{"date":"2024-11-22","current":-2.076001,"twenty":-2.988805,"median":-2.341497,"eighty":-1.465271,"marketCap":53850185},{"date":"2024-11-29","current":-2.158258,"twenty":-2.975456,"median":-2.338036,"eighty":-1.469425,"marketCap":55983872},{"date":"2024-12-06","current":-1.933643,"twenty":-2.972266,"median":-2.332214,"eighty":-1.472826,"marketCap":50157496},{"date":"2024-12-13","current":-1.96294,"twenty":-2.967505,"median":-2.321643,"eighty":-1.479063,"marketCap":50917458},{"date":"2024-12-20","current":-1.992238,"twenty":-2.962612,"median":-2.316763,"eighty":-1.498022,"marketCap":51677420},{"date":"2024-12-27","current":-1.992238,"twenty":-2.961258,"median":-2.307373,"eighty":-1.503103,"marketCap":51677420},{"date":"2025-01-03","current":-2.041067,"twenty":-2.956932,"median":-2.307355,"eighty":-1.507276,"marketCap":52944024},{"date":"2025-01-10","current":-2.080131,"twenty":-2.941372,"median":-2.303098,"eighty":-1.515197,"marketCap":53957306},{"date":"2025-01-17","current":-1.972706,"twenty":-2.899372,"median":-2.296637,"eighty":-1.531004,"marketCap":51170779},{"date":"2025-01-24","current":-1.933643,"twenty":-2.87533,"median":-2.284723,"eighty":-1.538485,"marketCap":50157496},{"date":"2025-01-31","current":-1.875661,"twenty":-2.867606,"median":-2.264784,"eighty":-1.540033,"marketCap":48653485},{"date":"2025-02-07","current":-1.996671,"twenty":-2.860087,"median":-2.25627,"eighty":-1.544371,"marketCap":51792420},{"date":"2025-02-14","current":-1.885745,"twenty":-2.856098,"median":-2.247756,"eighty":-1.551399,"marketCap":48915063},{"date":"2025-02-21","current":-1.915998,"twenty":-2.84995,"median":-2.243914,"eighty":-1.558143,"marketCap":49699797},{"date":"2025-02-28","current":-1.986587,"twenty":-2.835718,"median":-2.237919,"eighty":-1.561594,"marketCap":51530842},{"date":"2025-03-07","current":-1.854501,"twenty":-2.835615,"median":-2.232622,"eighty":-1.563808,"marketCap":48104595},{"date":"2025-03-14","current":-1.703553,"twenty":-2.834917,"median":-2.225582,"eighty":-1.566156,"marketCap":44189105},{"date":"2025-03-21","current":-1.897628,"twenty":-2.832683,"median":-2.223693,"eighty":-1.572339,"marketCap":49223306},{"date":"2025-03-28","current":-2.073878,"twenty":-2.8282,"median":-2.216853,"eighty":-1.577368,"marketCap":48227321},{"date":"2025-04-04","current":-2.022985,"twenty":-2.827663,"median":-2.202461,"eighty":-1.578876,"marketCap":47043829},{"date":"2025-04-11","current":-1.857584,"twenty":-2.825689,"median":-2.188156,"eighty":-1.588437,"marketCap":43197478},{"date":"2025-04-17","current":-1.959369,"twenty":-2.817793,"median":-2.17779,"eighty":-1.602543,"marketCap":45564463},{"date":"2025-04-25","current":-2.671867,"twenty":-2.813564,"median":-2.188156,"eighty":-1.606359,"marketCap":62133359},{"date":"2025-05-02","current":-3.155348,"twenty":-2.827663,"median":-2.19667,"eighty":-1.631509,"marketCap":73376538},{"date":"2025-05-09","current":-2.493743,"twenty":-2.817793,"median":-2.215276,"eighty":-1.659151,"marketCap":57991135},{"date":"2025-05-16","current":-2.722426,"twenty":-2.827663,"median":-2.222213,"eighty":-1.659151,"marketCap":53643944},{"date":"2025-05-23","current":-2.753188,"twenty":-2.817793,"median":-2.225582,"eighty":-1.671207,"marketCap":54250090},{"date":"2025-05-30","current":-2.78395,"twenty":-2.815328,"median":-2.228422,"eighty":-1.673266,"marketCap":54856236},{"date":"2025-06-06","current":-2.999283,"twenty":-2.815328,"median":-2.236289,"eighty":-1.687454,"marketCap":59099260},{"date":"2025-06-13","current":-2.691665,"twenty":-2.813794,"median":-2.242361,"eighty":-1.695662,"marketCap":53037797},{"date":"2025-06-20","current":-2.768569,"twenty":-2.813356,"median":-2.24629,"eighty":-1.696859,"marketCap":54553163},{"date":"2025-06-27","current":-2.676284,"twenty":-2.813356,"median":-2.250825,"eighty":-1.698098,"marketCap":52734724},{"date":"2025-07-03","current":-2.845474,"twenty":-2.814253,"median":-2.264726,"eighty":-1.69915,"marketCap":56068529},{"date":"2025-07-11","current":-2.968522,"twenty":-2.827663,"median":-2.264784,"eighty":-1.701114,"marketCap":58493114},{"date":"2025-07-18","current":-2.737807,"twenty":-2.823715,"median":-2.284723,"eighty":-1.703553,"marketCap":53947017},{"date":"2025-07-25","current":-2.630141,"twenty":-2.816561,"median":-2.297739,"eighty":-1.703553,"marketCap":51825505},{"date":"2025-08-01","current":-2.414808,"twenty":-2.814712,"median":-2.307355,"eighty":-1.704922,"marketCap":47582481},{"date":"2025-08-08","current":-2.276379,"twenty":-2.814253,"median":-2.307364,"eighty":-1.709911,"marketCap":44854823},{"date":"2025-08-15","current":-3.182597,"twenty":-2.827663,"median":-2.314914,"eighty":-1.7146,"marketCap":51469423},{"date":"2025-08-22","current":-3.121393,"twenty":-2.83463,"median":-2.320217,"eighty":-1.715028,"marketCap":50479626},{"date":"2025-08-29","current":-3.100992,"twenty":-2.845474,"median":-2.326175,"eighty":-1.71681,"marketCap":50149694},{"date":"2025-09-05","current":-3.039788,"twenty":-2.856962,"median":-2.332248,"eighty":-1.72061,"marketCap":49159897},{"date":"2025-09-12","current":-3.468214,"twenty":-2.877494,"median":-2.337903,"eighty":-1.72632,"marketCap":56088474},{"date":"2025-09-19","current":-3.202998,"twenty":-2.948857,"median":-2.33896,"eighty":-1.734352,"marketCap":51799355},{"date":"2025-09-26","current":-3.202998,"twenty":-2.967408,"median":-2.345739,"eighty":-1.747235,"marketCap":51799355},{"date":"2025-10-03","current":-3.672227,"twenty":-2.976985,"median":-2.34725,"eighty":-1.747235,"marketCap":59387796},{"date":"2025-10-10","current":-3.509017,"twenty":-3.007656,"median":-2.358441,"eighty":-1.748718,"marketCap":56748338},{"date":"2025-10-17","current":-2.75417,"twenty":-3.008543,"median":-2.366511,"eighty":-1.754778,"marketCap":44540847},{"date":"2025-10-24","current":-2.978584,"twenty":-3.007656,"median":-2.37828,"eighty":-1.756896,"marketCap":48170101},{"date":"2025-10-31","current":-2.672565,"twenty":-3.007656,"median":-2.383983,"eighty":-1.763338,"marketCap":43221118},{"date":"2025-11-07","current":-2.244139,"twenty":-3.004309,"median":-2.379435,"eighty":-1.763338,"marketCap":36292542},{"date":"2025-11-14","current":-1.674294,"twenty":-2.999223,"median":-2.377326,"eighty":-1.748718,"marketCap":37402630},{"date":"2025-11-21","current":-1.443871,"twenty":-2.998653,"median":-2.366294,"eighty":-1.72632,"marketCap":32255139},{"date":"2025-11-28","current":-1.956106,"twenty":-2.997323,"median":-2.358441,"eighty":-1.721124,"marketCap":43698122},{"date":"2025-12-05","current":-1.98926,"twenty":-2.978584,"median":-2.34725,"eighty":-1.724025,"marketCap":44438768},{"date":"2025-12-12","current":-2.718655,"twenty":-2.977224,"median":-2.346358,"eighty":-1.725117,"marketCap":60732983},{"date":"2025-12-19","current":-1.98926,"twenty":-2.976027,"median":-2.341497,"eighty":-1.731131,"marketCap":44438768},{"date":"2025-12-26","current":-2.45342,"twenty":-2.973743,"median":-2.341497,"eighty":-1.744014,"marketCap":54807814},{"date":"2026-01-02","current":-2.620787,"twenty":-2.970455,"median":-2.345739,"eighty":-1.747235,"marketCap":58546666},{"date":"2026-01-09","current":-2.843468,"twenty":-2.96857,"median":-2.347113,"eighty":-1.747235,"marketCap":63521219},{"date":"2026-01-16","current":-2.723563,"twenty":-2.965179,"median":-2.358441,"eighty":-1.751685,"marketCap":60842614},{"date":"2026-01-23","current":-4.111038,"twenty":-2.974885,"median":-2.366078,"eighty":-1.754905,"marketCap":91837908},{"date":"2026-01-30","current":-4.093909,"twenty":-2.990595,"median":-2.371936,"eighty":-1.758507,"marketCap":91455250},{"date":"2026-02-06","current":-3.271701,"twenty":-3.007134,"median":-2.379234,"eighty":-1.763338,"marketCap":73087668},{"date":"2026-02-13","current":-3.374477,"twenty":-3.016174,"median":-2.383983,"eighty":-1.763338,"marketCap":75383616},{"date":"2026-02-20","current":-3.5629,"twenty":-3.030889,"median":-2.383983,"eighty":-1.763338,"marketCap":79592853},{"date":"2026-02-27","current":-3.734193,"twenty":-3.039712,"median":-2.385818,"eighty":-1.763338,"marketCap":83419433},{"date":"2026-03-06","current":-4.017537,"twenty":-3.049862,"median":-2.392568,"eighty":-1.764948,"marketCap":89749155},{"date":"2026-03-13","current":-4.122571,"twenty":-3.060189,"median":-2.396586,"eighty":-1.771567,"marketCap":92095539},{"date":"2026-03-20","current":-3.938762,"twenty":-3.06481,"median":-2.399999,"eighty":-1.772274,"marketCap":87989368},{"date":"2026-03-27","current":-3.738436,"twenty":-3.077322,"median":-2.403689,"eighty":-1.772274,"marketCap":83726657},{"date":"2026-04-02","current":-3.630076,"twenty":-3.091579,"median":-2.414792,"eighty":-1.772274,"marketCap":81299797},{"date":"2026-04-10","current":-3.250814,"twenty":-3.101567,"median":-2.416424,"eighty":-1.779027,"marketCap":72805789},{"date":"2026-04-17","current":-3.602986,"twenty":-3.12045,"median":-2.426555,"eighty":-1.779027,"marketCap":80693083},{"date":"2026-04-24","current":-3.413355,"twenty":-3.138859,"median":-2.429844,"eighty":-1.779442,"marketCap":76446078},{"date":"2026-05-01","current":-3.602986,"twenty":-3.141794,"median":-2.430189,"eighty":-1.779442,"marketCap":80693083},{"date":"2026-05-08","current":-3.548805,"twenty":-3.151902,"median":-2.436946,"eighty":-1.787358,"marketCap":79479653},{"date":"2026-05-15","current":-3.402809,"twenty":-3.160645,"median":-2.440654,"eighty":-1.787494,"marketCap":82513227},{"date":"2026-05-22","current":-3.209467,"twenty":-3.162196,"median":-2.449568,"eighty":-1.794899,"marketCap":77824970},{"date":"2026-05-29","current":-3.234541,"twenty":-3.168124,"median":-2.452752,"eighty":-1.795416,"marketCap":78432977},{"date":"2026-06-05","current":-3.761094,"twenty":-3.186677,"median":-2.454213,"eighty":-1.795545,"marketCap":91201137},{"date":"2026-06-12","current":-3.259615,"twenty":-3.202998,"median":-2.458233,"eighty":-1.795545,"marketCap":79040985},{"date":"2026-06-18","current":-3.309763,"twenty":-3.20429,"median":-2.459855,"eighty":-1.798573,"marketCap":80257000},{"date":"2026-06-26","current":-3.384985,"twenty":-3.219198,"median":-2.466904,"eighty":-1.800591,"marketCap":82081023},{"date":"2026-07-02","current":-3.585576,"twenty":-3.223399,"median":-2.468445,"eighty":-1.800591,"marketCap":86945083},{"date":"2026-07-10","current":-3.660798,"twenty":-3.234541,"median":-2.478676,"eighty":-1.801793,"marketCap":88769106},{"date":"2026-07-17","current":-3.334837,"twenty":-3.243235,"median":-2.481254,"eighty":-1.808221,"marketCap":80865008},{"date":"2026-07-24","current":-3.209467,"twenty":-3.247477,"median":-2.487249,"eighty":-1.816839,"marketCap":77824970},{"date":"2026-07-31","current":-3.134245,"twenty":-3.243801,"median":-2.489247,"eighty":-1.819431,"marketCap":76000947},{"date":"2026-08-07","current":-3.560502,"twenty":-3.250814,"median":-2.49489,"eighty":-1.820809,"marketCap":86337076},{"date":"2026-08-14","current":-3.034921,"twenty":-3.250814,"median":-2.499534,"eighty":-1.82524,"marketCap":81473015},{"date":"2026-08-21","current":-3.126805,"twenty":-3.250637,"median":-2.503408,"eighty":-1.825742,"marketCap":83939664},{"date":"2026-08-28","current":-3.126805,"twenty":-3.248703,"median":-2.509815,"eighty":-1.827752,"marketCap":83939664},{"date":"2026-09-04","current":-3.013515,"twenty":-3.243801,"median":-2.511697,"eighty":-1.828629,"marketCap":80898372},{"date":"2026-09-11","current":-2.968199,"twenty":-3.243801,"median":-2.520211,"eighty":-1.832138,"marketCap":79681855},{"date":"2026-09-15","current":-3.149463,"twenty":-3.243235,"median":-2.525562,"eighty":-1.836858,"marketCap":84547923}],"updateTime":1789562994357},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MAIA\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2649999064","title":"Maia Biotechnology - Ateganosine Plus Cemiplimab Shows Acceptable Safety Profile in Heavily Pre-treated Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2649999064","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649999064?lang=en_us&edition=fundamental","pubTime":"2026-07-08 21:45","pubTimestamp":1783518300,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260708:nTUAQ7RJ8:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MAIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649990619","title":"Maia Biotechnology Reports Strong Initial Efficacy Data in Third-line Non-small Cell Lung Cancer from Phase 2 Thio-101 Part C Expansion Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2649990619","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649990619?lang=en_us&edition=fundamental","pubTime":"2026-07-08 21:45","pubTimestamp":1783518300,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260708:nTUAQ7RJ8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MAIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649799906","title":"Maia Biotechnology - Thio-101 Part C Shows 90.5% Disease Control Rate in 3L Nsclc","url":"https://stock-news.laohu8.com/highlight/detail?id=2649799906","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649799906?lang=en_us&edition=fundamental","pubTime":"2026-07-08 21:45","pubTimestamp":1783518300,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260708:nTUAQ7RJ8:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MAIA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649062999","title":"Maia Biotechnology - Ateganosine Plus Cemiplimab Outperforms Standard Chemotherapy Dcr in 3L Nsclc","url":"https://stock-news.laohu8.com/highlight/detail?id=2649062999","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649062999?lang=en_us&edition=fundamental","pubTime":"2026-07-08 21:45","pubTimestamp":1783518300,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260708:nTUAQ7RJ8:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MAIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646605870","title":"Maia Biotechnology Completes International Enrollment in Part C of Phase 2 Thio-101 Expansion Trial in Third-line Non-small Cell Lung Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2646605870","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646605870?lang=en_us&edition=fundamental","pubTime":"2026-06-25 20:08","pubTimestamp":1782389280,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260625:nTUA5MLKGH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MAIA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646870966","title":"MAIA Biotechnology Completes International Enrollment in Part C of Phase 2 THIO-101 Expansion Trial in Third-Line Non-Small Cell Lung Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2646870966","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646870966?lang=en_us&edition=fundamental","pubTime":"2026-06-25 20:08","pubTimestamp":1782389280,"startTime":"0","endTime":"0","summary":"Part C domestic enrollment is underway at three clinical sites in the U.S. CHICAGO, June  25, 2026  (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “Company”), a clinic","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/25/3317503/0/en/MAIA-Biotechnology-Completes-International-Enrollment-in-Part-C-of-Phase-2-THIO-101-Expansion-Trial-in-Third-Line-Non-Small-Cell-Lung-Cancer.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4588","LU2487616109.SGD","MAIA","ORR","LU0053666078.USD","CPI","LU0210528500.USD","BK4585","L","BK4107"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644810085","title":"Maia Biotech opens enrollment at Emory Winship for Phase 2 ateganosine NSCLC trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2644810085","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644810085?lang=en_us&edition=fundamental","pubTime":"2026-06-18 20:31","pubTimestamp":1781785888,"startTime":"0","endTime":"0","summary":"Maia Biotechnology opened enrollment at Emory University’s Winship Cancer Institute for its Phase 2 THIO-101 expansion trial in third-line NSCLC.The study evaluates ateganosine, a telomere-targeting agent, followed by cemiplimab in patients resistant to checkpoint inhibitors and chemotherapy.Early results from Parts A and B have already been presented, showing encouraging clinical benefit in some patients.The U.S. expansion adds a third domestic site, supporting broader recruitment for a setting with no FDA-approved third-line options.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260618:nNDLbNrbBV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","SG9999014013.SGD","IE00B64PRP62.GBP","NDAQ","IE00BN0W2W23.USD","BK4112","SG9999014021.USD","IE00BGHQF748.EUR","SG9999014005.SGD","SG9999014039.USD","IE00BKPKM429.USD","LU2210149790.SGD","BK4139","IE00BN0W2V16.EUR","BK4588","IE00BN0W2T93.GBP","LU0314104364.USD","MAIA","IE00B3QW5Z07.USD","LU2210150020.SGD","LU2095319765.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644808302","title":"Maia Biotechnology Opens Enrollment for Phase 2 Expansion Trial of Novel Telomere-Targeting Agent at Winship Cancer Institute of Emory University","url":"https://stock-news.laohu8.com/highlight/detail?id=2644808302","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644808302?lang=en_us&edition=fundamental","pubTime":"2026-06-18 20:30","pubTimestamp":1781785800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260618:nTUABM17DY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MAIA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167022508","title":"Compugen to Unveil Latest Data from MAIA Ovarian Cancer Drug Trial at European Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=1167022508","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167022508?lang=en_us&edition=fundamental","pubTime":"2026-06-11 23:20","pubTimestamp":1781191233,"startTime":"0","endTime":"0","summary":"Clinical-stage cancer immunotherapy company Compugen Ltd. announced on Thursday that it will present the latest progress from its MAIA-ovarian trial in a poster presentation at the 2026 European...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MAIA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642442946","title":"Maia Biotech opens enrollment at second US site for Phase 2 THIO-101 lung cancer trial expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2642442946","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642442946?lang=en_us&edition=fundamental","pubTime":"2026-06-10 21:20","pubTimestamp":1781097631,"startTime":"0","endTime":"0","summary":"Maia Biotechnology opened enrollment at a second US site for its Phase 2 THIO-101 expansion trial in third-line non-small cell lung cancer.No new results were presented; additional expansion data are expected in future interim updates to support a potential FDA accelerated approval filing.The study evaluates ateganosine in patients who failed checkpoint inhibitors and chemotherapy, aiming to show clinically meaningful benefit without detailing metrics.Maia is also screening patients for a pivotal Phase 3 overall-survival study comparing ateganosine sequenced with a CPI versus investigator’s-choice chemotherapy.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Maia Biotechnology Inc. published the original content used to generate this ne","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260610:nNDL6MN2LH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MAIA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642542915","title":"Maia Biotechnology Activates and Opens Enrollment at Second U.S. Clinical Site for International Phase 2 Thio-101 Expansion Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2642542915","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642542915?lang=en_us&edition=fundamental","pubTime":"2026-06-10 21:15","pubTimestamp":1781097300,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260610:nTUA2X2ZSG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MAIA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642209429","title":"MAIA Biotechnology Activates and Opens Enrollment at Second U.S. Clinical Site for International Phase 2 THIO-101 Expansion Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2642209429","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642209429?lang=en_us&edition=fundamental","pubTime":"2026-06-10 21:15","pubTimestamp":1781097300,"startTime":"0","endTime":"0","summary":"Additional data from MAIA’s THIO-101 expansion may further support an accelerated approval filing with the FDA Potential breakthrough therapy holds substantial commercial opportunity in a projected $7","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/10/3309785/0/en/MAIA-Biotechnology-Activates-and-Opens-Enrollment-at-Second-U-S-Clinical-Site-for-International-Phase-2-THIO-101-Expansion-Trial.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4107","MAIA","L","CPI","ORR","BK4585","BK4588","BK4081","LU0210528500.USD","LU0053666078.USD","LU2487616109.SGD","EMA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640316357","title":"MAIA Biotechnology reports 29 patients dosed in Phase 3 THIO-104 trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2640316357","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640316357?lang=en_us&edition=fundamental","pubTime":"2026-06-04 21:50","pubTimestamp":1780581010,"startTime":"0","endTime":"0","summary":"MAIA Biotechnology (MAIA) provided a patient enrollment update for its ongoing pivotal Phase 3 trial, THIO-104, evaluating its novel telomere-targe...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/maia-biotechnology-reports-29-patients-dosed-in-phase-3-thio-104-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/maia-biotechnology-reports-29-patients-dosed-in-phase-3-thio-104-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MAIA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640687421","title":"MAIA Biotech doses 29 patients in Phase 3 THIO-104 lung cancer trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2640687421","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640687421?lang=en_us&edition=fundamental","pubTime":"2026-06-04 21:45","pubTimestamp":1780580714,"startTime":"0","endTime":"0","summary":"Maia Biotechnology reported strong enrollment momentum in THIO-104, a pivotal Phase 3 trial of ateganosine in third-line advanced non-small cell lung cancer.No new efficacy results were presented; the update focused on trial progress and timing for future readouts.29 patients have been dosed across 34 active sites in six countries, with a target of up to 100 patients by year-end.An interim analysis is expected in 2027 once survival follow-up matures, setting the next key catalyst for the program.Ateganosine holds FDA Fast Track status, supporting a potentially accelerated development and regulatory path if Phase 3 data are positive.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260604:nNDL9HYVqc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","SG9999014039.USD","SG9999014013.SGD","LU2210149790.SGD","IE00BN0W2T93.GBP","BK4112","BK4139","LU0314104364.USD","SG9999014005.SGD","IE00BN0W2W23.USD","NDAQ","IE00B64PRP62.GBP","LU2095319765.USD","LU2210150020.SGD","IE00B3QW5Z07.USD","MAIA","SG9999014021.USD","IE00BKPKM429.USD","BK4585","BK4588","IE00BN0W2V16.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640168788","title":"Maia Biotechnology Reports Strong Enrollment and Dosing Momentum in Pivotal Phase 3 Non-Small Cell Lung Cancer Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2640168788","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640168788?lang=en_us&edition=fundamental","pubTime":"2026-06-04 21:45","pubTimestamp":1780580700,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260604:nTUA4MW6GB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MAIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640900487","title":"MAIA Gets FDA Clearance for Enrollment in Expanded Phase 2 Cancer Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2640900487","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640900487?lang=en_us&edition=fundamental","pubTime":"2026-06-03 22:23","pubTimestamp":1780496602,"startTime":"0","endTime":"0","summary":"MAIA Biotechnology  said Wednesday it has received clearance from the US Food and Drug Administration to open enrollment for the expansion of the phase 2 THIO-101 trial of ateganosine for advanced non-small cell lung cancer.The firm said it obtained clearance of its updated investigational new drug application highlighting improved manufacturing capabilities, including new manufacturers and formulation.In addition to the US, the THIO-101 study is ongoing at 44 clinical sites in six countries, it added.The additional data from the expansion studies may further support a filing for an accelerated approval, MAIA said.Shares were up over 4% in morning trading.Price: 1.41, Change: +0.06, Percent Change: +4.44","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","BK4139","BK4585","MAIA","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640900874","title":"MAIA Biotechnology receives FDA clearance for amendment to IND application","url":"https://stock-news.laohu8.com/highlight/detail?id=2640900874","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640900874?lang=en_us&edition=fundamental","pubTime":"2026-06-03 21:55","pubTimestamp":1780494955,"startTime":"0","endTime":"0","summary":"MAIA Biotechnology (MAIA) announced that the U.S. Food and Drug Administration has cleared an amendment to update its investigational new drug appl...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/maia-biotechnology-receives-fda-clearance-for-amendment-to-ind-application-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/maia-biotechnology-receives-fda-clearance-for-amendment-to-ind-application-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4585","BK4139","IND","MAIA","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640690716","title":"Maia Biotechnology Receives FDA Clearance to Open U.S. Enrollment in Ongoing Phase 2 Thio-101 Trial Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2640690716","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640690716?lang=en_us&edition=fundamental","pubTime":"2026-06-03 21:45","pubTimestamp":1780494300,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nTUA8ZYMYV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MAIA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640946299","title":"MAIA Biotechnology announces open market purchases by CEO, director","url":"https://stock-news.laohu8.com/highlight/detail?id=2640946299","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640946299?lang=en_us&edition=fundamental","pubTime":"2026-06-02 21:52","pubTimestamp":1780408340,"startTime":"0","endTime":"0","summary":"MAIA Biotechnology (MAIA) announced that its founder and CEO Vlad Vitoc, M.D. and Director Stan Smith, Ph.D. have increased their ownership positio...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/maia-biotechnology-announces-open-market-purchases-by-ceo-director-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/maia-biotechnology-announces-open-market-purchases-by-ceo-director-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","MAIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640946283","title":"Analysts Offer Insights on Healthcare Companies: West Pharmaceutical Services (WST) and MAIA Biotechnology, Inc. (MAIA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2640946283","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640946283?lang=en_us&edition=fundamental","pubTime":"2026-06-02 21:50","pubTimestamp":1780408234,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on West Pharmaceutical Services (WST) and MAIA Biotechn...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-west-pharmaceutical-services-wst-and-maia-biotechnology-inc-maia-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-west-pharmaceutical-services-wst-and-maia-biotechnology-inc-maia-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MAIA","LU0012050646.USD","XLV","BK4567","BK4588","BK4585","BK4139","LU0029874061.USD","BK4137","LU0128526141.USD","LU0345774391.USD","LABU","IE00BYQQ9H92.USD","BK4581","BK4504","IE00BFXG0V08.USD","HCSG","LU0106261612.USD","WST","XBI","BK4121","LU0345774631.USD","IE00B64QTZ34.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":67,"code":"91000000","status":"200"}]}}